Who funds MS research
Running trials in each area by who pays for them.
- Industry
- Government
- Academic and charities
- Other
Preventing MS
100%
4 runningStopping relapses
50%44%
62 runningSlowing progression
40%53%
40 runningProtecting and repairing
91%
23 runningEasing symptoms
92%
196 runningTowards a cure
26%71%
38 runningIndustry funds 50% of running trials on stopping relapses and 4% of those on protecting and repairing.
Running and stopped trials
| Area | Funder | Running | Stopped | Share stopped |
|---|---|---|---|---|
| Preventing MS | Industry | 0 | 5 | 26% |
| Preventing MS | Government | 0 | 0 | 0% |
| Preventing MS | Academic and charities | 4 | 3 | 19% |
| Stopping relapses | Industry | 31 | 53 | 24% |
| Stopping relapses | Government | 3 | 2 | 13% |
| Stopping relapses | Academic and charities | 27 | 26 | 18% |
| Stopping relapses | Other | 1 | 0 | 0% |
| Slowing progression | Industry | 16 | 19 | 22% |
| Slowing progression | Government | 2 | 0 | 0% |
| Slowing progression | Academic and charities | 21 | 14 | 18% |
| Slowing progression | Other | 1 | 0 | 0% |
| Protecting and repairing | Industry | 1 | 5 | 25% |
| Protecting and repairing | Government | 0 | 1 | 33% |
| Protecting and repairing | Academic and charities | 21 | 11 | 15% |
| Protecting and repairing | Other | 1 | 0 | 0% |
| Easing symptoms | Industry | 7 | 14 | 18% |
| Easing symptoms | Government | 8 | 4 | 10% |
| Easing symptoms | Academic and charities | 180 | 36 | 4% |
| Easing symptoms | Other | 1 | 0 | 0% |
| Towards a cure | Industry | 10 | 14 | 25% |
| Towards a cure | Government | 1 | 1 | 20% |
| Towards a cure | Academic and charities | 27 | 10 | 12% |
| Towards a cure | Other | 0 | 0 | 0% |
Assembled by software from public sources.